Anandan Palani

2.8k total citations
67 papers, 1.7k citations indexed

About

Anandan Palani is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Anandan Palani has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Organic Chemistry and 10 papers in Immunology. Recurrent topics in Anandan Palani's work include Quinazolinone synthesis and applications (8 papers), Chemical Synthesis and Analysis (7 papers) and HIV Research and Treatment (7 papers). Anandan Palani is often cited by papers focused on Quinazolinone synthesis and applications (8 papers), Chemical Synthesis and Analysis (7 papers) and HIV Research and Treatment (7 papers). Anandan Palani collaborates with scholars based in United States, China and Italy. Anandan Palani's co-authors include E. J. Corey, John W. Clader, Robert Aslanian, Jayaram R. Tagat, Xianhai Huang, Bahige M. Baroudy, Sherry Shapiro, William J. Greenlee, Julie Strizki and Stuart W. McCombie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Anandan Palani

67 papers receiving 1.6k citations

Peers

Anandan Palani
M. Arshad Siddiqui United States
Ralph T. Mosley United States
Andrew J. Peat United States
Robert Déziel Canada
Tom D. Heightman United Kingdom
Per-Olof Markgren Sweden
Vincent J. Kalish United States
Soo S. Ko United States
Mario Cardozo United States
Soon Kil Ahn South Korea
M. Arshad Siddiqui United States
Anandan Palani
Citations per year, relative to Anandan Palani Anandan Palani (= 1×) peers M. Arshad Siddiqui

Countries citing papers authored by Anandan Palani

Since Specialization
Citations

This map shows the geographic impact of Anandan Palani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anandan Palani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anandan Palani more than expected).

Fields of papers citing papers by Anandan Palani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anandan Palani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anandan Palani. The network helps show where Anandan Palani may publish in the future.

Co-authorship network of co-authors of Anandan Palani

This figure shows the co-authorship network connecting the top 25 collaborators of Anandan Palani. A scholar is included among the top collaborators of Anandan Palani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anandan Palani. Anandan Palani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maddess, Matthew L., David L. Sloman, Xiaoshen Ma, et al.. (2023). Abstract B074: Discovery of MK-1084, a low dose selective clinical stage KRAS G12C inhibitor. Molecular Cancer Therapeutics. 22(12_Supplement). B074–B074. 1 indexed citations
2.
Huang, Chunhui, Anandan Palani, Qiaolin Deng, et al.. (2022). Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity. ACS Medicinal Chemistry Letters. 13(8). 1255–1261. 1 indexed citations
3.
Xiao, Dong, Xing Dai, Hong Liu, et al.. (2020). Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B. Bioorganic & Medicinal Chemistry Letters. 30(7). 127004–127004. 4 indexed citations
4.
Demartis, Anna, Armin Lahm, Licia Tomei, et al.. (2018). Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library. Scientific Reports. 8(1). 585–585. 9 indexed citations
5.
Zhao, Zhiqiang, Dmitri Pissarnitski, Xianhai Huang, et al.. (2017). Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators. ACS Medicinal Chemistry Letters. 8(10). 1002–1006. 10 indexed citations
6.
Huang, Xianhai, Wei Zhou, Robert Aslanian, et al.. (2017). The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh2 antagonists. Bioorganic & Medicinal Chemistry Letters. 27(23). 5344–5348. 7 indexed citations
7.
Xiao, Dong, Anandan Palani, Xianhai Huang, et al.. (2013). Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(11). 3262–3266. 21 indexed citations
8.
Shao, Ning, Robert Aslanian, Robert E. West, et al.. (2012). Synthesis and structure–activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(5). 2075–2078. 4 indexed citations
9.
Xiao, Dong, Anandan Palani, Robert Aslanian, et al.. (2012). Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(9). 3354–3357. 3 indexed citations
10.
Huang, Xianhai, Jing Su, Wei Zhou, et al.. (2011). SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist. Bioorganic & Medicinal Chemistry Letters. 22(2). 854–858. 12 indexed citations
11.
Huang, Xianhai, Xiaohong Zhu, Xiaohong Chen, et al.. (2011). A three-step protocol for lead optimization: Quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(1). 65–70. 18 indexed citations
12.
Xiao, Dong, Cheng Wang, Anandan Palani, et al.. (2010). Discovery of a series of potent, orally active α,α-disubstituted piperidine NK1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(21). 6313–6315. 10 indexed citations
13.
Xiao, Dong, Anandan Palani, Ying Huang, et al.. (2010). Discovery of a series of potent arylthiadiazole H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 861–864. 8 indexed citations
14.
Qin, Jun, Xianhai Huang, Mihirbaran Mandal, et al.. (2010). Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 21(2). 664–669. 19 indexed citations
15.
Palani, Anandan, Xiao Cheng, Ying Huang, et al.. (2009). Synthesis and structure–activity relationships of 2-(1,4′-bipiperidin-1′-yl)thiazolopyridine as H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(21). 6176–6180. 32 indexed citations
16.
Xu, Ruo, Shengjian Li, Mark D. McBriar, et al.. (2006). Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists. Bioorganic & Medicinal Chemistry. 14(10). 3285–3299. 22 indexed citations
17.
Seibert, Christoph, Weiwen Ying, Svetlana Gavrilov, et al.. (2006). Interaction of small molecule inhibitors of HIV-1 entry with CCR5. Virology. 349(1). 41–54. 99 indexed citations
18.
Palani, Anandan, Sherry Shapiro, Mark D. McBriar, et al.. (2005). Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity. Journal of Medicinal Chemistry. 48(15). 4746–4749. 54 indexed citations
19.
Palani, Anandan, et al.. (2003). Structure-Activity Relationship Studies: M2 and CCR5 Receptor Antagonists. Current Topics in Medicinal Chemistry. 3(10). 1155–1169. 3 indexed citations
20.
Palani, Anandan, Sherry Shapiro, John W. Clader, et al.. (2003). Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides. Bioorganic & Medicinal Chemistry Letters. 13(4). 709–712. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Arshad Siddiqui Breakdown of academic impact, for papers by Ralph T. Mosley Breakdown of academic impact, for papers by Andrew J. Peat Breakdown of academic impact, for papers by Robert Déziel Breakdown of academic impact, for papers by Tom D. Heightman Breakdown of academic impact, for papers by Per-Olof Markgren Breakdown of academic impact, for papers by Vincent J. Kalish Breakdown of academic impact, for papers by Soo S. Ko Breakdown of academic impact, for papers by Mario Cardozo Breakdown of academic impact, for papers by Soon Kil Ahn
Rankless by CCL
2026